$279.95
1.190.43%
At close: -
$277.42
-2.53-0.90%
After Hours: 5:06 PM EDT
Amgen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amgen using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $5.58 | $5.11 | 9.20 % |
Jun 2024 | 2024-08-06 | $4.97 | $5.00 | -0.60 % |
Mar 2024 | 2024-05-02 | $3.96 | $3.87 | 2.33 % |
Dec 2023 | 2024-02-06 | $4.71 | $4.62 | 1.95 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $8.50B | $8.52B | -0.20 % |
Jun 2024 | 2024-08-06 | $8.39B | $8.33B | 0.70 % |
Mar 2024 | 2024-05-02 | $7.45B | $6.94B | 7.31 % |
Dec 2023 | 2024-02-06 | $8.20B | $8.13B | 0.81 % |
Amgen (AMGN) is scheduled to report earnings on February 4, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $5.58, which beat the estimate of $5.11.
The Actual Revenue was $8.5B, which missed the estimate of $8.5B.
Browse earnings estimates, EPS, and revenue on all stocks.